advanced research hub

A study to test different doses of BI 3923948 alone and in combination with an anti-PD-1 antibody in people with different types of advanced cancer (solid tumors)

This study is testing a new medicine, BI 3923948, on its own and with another cancer drug (an anti-PD-1 antibody). It's for adults with advanced cancers that have spread or can't be removed, to see how safe it is and how different doses work.